Elixinol Wellness says the latest lab tests on its hemp extract, published in the Journal of Toxicology, showed “positive safety results”, with further tests needed to confirm its safety for humans. The extract contains a blend of hemp extract, cannabidiol (CBD) isolate, and copaiba.
In Australia, Elixinol Wellness operates a vertically integrated business which produces, manufactures, and distributes a range of products delivered across four verticals – human nutrition, human wellness, pet wellness and superfood ingredients.
These products are sold under brands including Hemp Foods Australia, Mt Elephant and Field Day and are sold through grocery, wholesale, and e-commerce channels. The Australian Superfood Co supplies Australian natives and superfood ingredients to white label customers including food, beverage, and beauty manufacturers.
The paper, Safety of Elixinol Hemp Extract: In VitroGenetic Toxicity and Subchronic Toxicity in Rats, reported the safety studies of Elixinol Hemp Extract when tested on rats and concluded that the extract was safe to use and did not have any adverse effects at the highest dose tested. The paper also suggested that the Elixinol Hemp Extract may have some benefits for human health, with additional studies needed to confirm this.
The paper details two studies that tested the effects of the Elixinol Hemp Extract on rats. The first study was a short-term 15-day study and the second was a long-term 90-day study. The study found that the Extract did not cause any harmful effects on the rats. It did note some changes in the rats’ liver cells and liver weight, however these changes were not serious and did not affect the liver function. The changes also reversed once the Extract was stopped.
Elixinol group CEO and MD, Ron Dufficy said: “The positive safety results stand Elixinol Hemp Extract and Elixinol more broadly in good stead for the future of our hemp products and offerings.”
The paper concluded that the results from the studies indicated that Elixinol Hemp Extract is well tolerated in male and female Sprague–Dawley rats, and that the information contributed to the growing amount of safety information available for hemp extracts.
The full paper can be viewed here.
